Asian Pacific Journal of Allergy and Immunology

Aims & Scope

The Asian Pacific Journal of Allergy and Immunology (APJAI) is an online open access journal with the recent impact factor (2018) 1.747 APJAI published 4 times per annum (March, June, September, December).

Four issues constitute one volume.

APJAI publishes original research articles of basic science, clinical science and reviews on various aspects of allergy and immunology.

This journal is an official journal of and published by the Allergy, Asthma and Immunology Association, Thailand.

The scopes include mechanism, pathogenesis, host-pathogen interaction, host-environment interaction, allergic diseases, immune-mediated diseases, epidemiology, diagnosis, treatment and prevention, immunotherapy, and vaccine.

All papers are published in English and are refereed to international standards.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	2.30

Journal Rank

Year	Value
2024	11496

Journal Citation Indicator

Year	Value
2024	256

SJR (SCImago Journal Rank)

Year	Value
2024	0.505

Quartile

Year	Value
2024	Q3

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic

  Citation: 381

  Authors:

• Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)

  Citation: 111

  Authors:

• Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: A comparison using control sera obtained from healthy individuals and patients with multiple medical problems

  Citation: 58

  Authors: Ramjai

• Adverse reactions to iodinated contrast media: prevalence, risk factors and outcome – the results of a 3-year period

  Citation: 40

  Authors: Panitan

• Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options

  Citation: 26

  Authors:

• Two year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing subcutaneous and sublingual immunotherapy

  Citation: 25

  Authors: Ayfer

• The potential impact of gut on your health: Current status and future challenges

  Citation: 24

  Authors:

• The role of Treg cell subsets in allergic disease

  Citation: 24

  Authors:

• Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients

  Citation: 22

  Authors: Patipat

• Aeroallergen sensitization and allergic disease phenotypes in Asia

  Citation: 20

  Authors:

---